Who
AmirAli Talasaz
Co-Chief Executive Officer
Company insider
Files Form 4 as: Co-Chief Executive Officer, Guardant Health.
In numbers
- Trades disclosed
- 664
- Buys
- 4
- Sells
- 67
- Bought
- $12.5M
- Sold
- $558.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Oct 2018
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —23,997 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —9,716 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $3.0M17,087 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —23,997 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —9,716 at $0.00 | filing |
| 30 Sep 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,817 at $0.00 | filing |
| 30 Sep 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $255K1,428 at $178.36 | filing |
| 30 Sep 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,817 at $0.00 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.5M9,023 at $168.20 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $3.5M20,888 at $169.16 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.3M7,589 at $170.29 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.5M9,023 at $168.20 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $3.5M20,888 at $169.16 | filing |
| 21 Aug 2026filed 24 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.3M7,589 at $170.29 | filing |
| 10 Aug 2026filed 12 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code G | —75,000 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code G | —75,000 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code G | —75,000 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code G | —75,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —23,997 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —23,997 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name AmirAli Talasaz; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.